The Changing Landscape of Alopecia Areata: The Translational Landscape

    June 2017 in “ Advances in Therapy
    Etienne C.E. Wang, Angela M. Christiano
    Image of study
    TLDR New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.
    The 2017 review outlined advancements in the understanding and treatment of Alopecia Areata (AA), emphasizing the role of genetic studies in identifying key genes and pathways, such as the JAK-STAT signaling pathway, which led to the use of JAK inhibitors with promising results. It also discussed the potential of other treatments like abatacept, simvastatin/ezetimibe, and biologic therapies targeting IL-15, IFN-y, and IL-2, with low-dose IL-2 showing modest results. The review highlighted the use of non-invasive diagnostic tools and the ALADIN index for disease activity assessment. It concluded that ongoing research and a deeper understanding of the immune system are paving the way for more precise and personalized treatments for AA, though larger studies are needed to confirm the efficacy of some of these treatments. The work was supported by NIH Grant P50 AR070588-01, and no new data were generated or analyzed for this review.
    Discuss this study in the Community →

    Cited in this study

    15 / 15 results

    Related

    6 / 6 results